跳至主要内容
临床试验/ITMCTR2000003245
ITMCTR2000003245招募中1 期

ingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial

The First Afflicated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. in line with epidemiological history survey and negative forCOVID-19 RNA screening
  • 2. in line with inclusion criteria and voluntarily receive fire needle treatment
  • 3. Aged 18 to 65 years old;
  • 4. Quality of life score<=37;
  • 5. Voluntary participation in this study and sign informed consent.

排除标准

  • 1. People who are taking anticoagulant drugs (such as warfarin), or have received other related treatments, may affect the indicators of this study;
  • 2. Pregnant women;
  • 3. Those who cannot tolerate fire needles due to allergies, stress, etc.

研究者

发起方
The First Afflicated Hospital of Guangzhou University of Chinese Medicine

相似试验